Skip to content
Abstract
No abstract available from the source.
Related reading
-
Acute 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity Leading to Fulminant Hepatic Failure and Emergency Liver Transplantation
Cureus • December 20, 2025 • via OpenAlex
-
Severe Rhabdomyolysis and Acute Kidney Injury Following Ayahuasca‐Related Trauma: A Case Report
Underline Science Inc. • October 7, 2025 • via OpenAlex
-
Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review
Health Psychology Research • October 6, 2022 • via OpenAlex
-
A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults
Journal of Psychopharmacology • February 15, 2022 • via OpenAlex
-
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials
Human Psychopharmacology Clinical and Experimental • February 2, 2022 • via OpenAlex